PRESS RELEASE published on 03/21/2024 at 10:00, 1 year 10 months ago Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply Eckert & Ziegler BEBIG GmbH, a subsidiary of Eckert & Ziegler SE, obtains MDR certification for proprietary prostate seeds from DEKRA Certification B.V., ensuring patient safety and long-term supply within the EU DEKRA Certification Eckert & Ziegler MDR Certification Prostate Seeds Brachytherapy
BRIEF published on 03/19/2024 at 19:51, 1 year 10 months ago Eckert & Ziegler Announces Dividend Cut to Fund Future Investments Investment Eckert & Ziegler Financial Forecast Dividend Reduction Radiopharmaceuticals
BRIEF published on 03/19/2024 at 19:51, 1 year 10 months ago Eckert & Ziegler annonce une réduction de ses dividendes pour financer ses investissements futurs Investissement Eckert & Ziegler Prévisions Financières Réduction Des Dividendes Produits Radiopharmaceutiques
PRESS RELEASE published on 03/19/2024 at 19:46, 1 year 10 months ago EQS-Adhoc: Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024. Eckert & Ziegler reduces dividend to fund future investments, aiming for earnings growth in 2024. Details on financial performance and strategic moves disclosed Financial Performance Eckert & Ziegler Earnings Growth Dividend Reduction Strategic Investments
BRIEF published on 03/19/2024 at 10:58, 1 year 10 months ago Eckert & Ziegler Transitions to Societas Europaea Corporate Governance Shareholder Rights Eckert & Ziegler SE Societas Europaea Legal Transition
BRIEF published on 03/19/2024 at 10:58, 1 year 10 months ago Eckert & Ziegler rejoint Societas Europaea Société Européenne Gouvernance D'Entreprise Droits Des Actionnaires Eckert & Ziegler SE Transition Juridique
PRESS RELEASE published on 03/19/2024 at 10:53, 1 year 10 months ago Eckert & Ziegler Completes Change of Legal Form to SE Eckert & Ziegler completes change of legal form to SE, maintaining shareholder equity and operations. The company is a leading specialist in nuclear medicine and radiation therapy Eckert & Ziegler Legal Form SE Nuclear Medicine Radiation Therapy
BRIEF published on 02/28/2024 at 10:00, 1 year 11 months ago Eckert & Ziegler Étend Ses Activités sur le Ga-68 au Japon en Collaboration avec Novartis Eckert & Ziegler Imagerie Médicale Diagnostic Gallium-68 Novartis Pharma K.K.
BRIEF published on 02/28/2024 at 10:00, 1 year 11 months ago Eckert & Ziegler Expands Ga-68 Activities in Japan in Collaboration with Novartis Eckert & Ziegler Medical Imaging Diagnostic Gallium-68 Novartis Pharma KK
PRESS RELEASE published on 02/28/2024 at 10:00, 1 year 11 months ago Eckert & Ziegler Extends Ga-68 Activities in Japan Eckert & Ziegler extends Ga-68 activities in Japan in alliance with Novartis Pharma K.K. Clinical trial with GalliaPharm generator for Ga-68. Collaboration to enhance cancer therapies and diagnostics in Japan Eckert & Ziegler Clinical Trial Japan Ga-68 Radiopharmaceutical Industry
Published on 02/05/2026 at 16:40, 50 minutes ago Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 1 hour 45 minutes ago American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 2 hours 20 minutes ago Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 2 hours 40 minutes ago High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 3 hours ago Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 17:05, 25 minutes ago European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels
Published on 02/05/2026 at 16:20, 1 hour 10 minutes ago Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 02/05/2026 at 16:20, 1 hour 10 minutes ago Birla Carbon Launches New Continua™ SCM Production Line in Italy
Published on 02/05/2026 at 15:56, 1 hour 34 minutes ago Original-Research: Verve Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 02/05/2026 at 16:04, 1 hour 26 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 02/05/2026 at 16:02, 1 hour 27 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 02/05/2026 at 11:30, 6 hours ago Déclaration nombre d'actions et droits de vote - 05.02.2026
